Results 251 to 260 of about 80,496 (306)

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Aluminium adjuvants in vaccines and potential health effects: systematic review.

open access: yesBMJ
Doyon-Plourde P   +6 more
europepmc   +1 more source

Hepatitis A vaccines and the elderly

open access: yesTravel Medicine and Infectious Disease, 2006
Hepatitis A virus (HAV) exposure in unprotected adults may cause severe and serious symptoms, with risk of both morbidity and mortality increasing with age. As seroprevalence of HAV is low in industrialised countries, and an increasing number of people, with an increasing median age, travel from areas of low HAV endemicity to high endemicity, pre ...
Genton, Blaise   +4 more
openaire   +5 more sources

Hepatitis Vaccines

Digestive Diseases, 2008
Viral hepatitis accounts for substantial morbidity and mortality worldwide, To date, the molecular sequences of six hepatotropic viruses have been described and designated hepatitis A, B, C, D, E, and G. Various methods have been employed to decrease the occurrence of these diseases, and advances in vaccination strategies have aided in prevention of ...
C A, Petruff   +3 more
openaire   +2 more sources

HEPATITIS VACCINES

Gastroenterology Clinics of North America, 1995
The 1980s represented a decade of breakthroughs for the development of hepatitis vaccines. Plasma-derived and then recombinant hepatitis B vaccines were developed and introduced, killed hepatitis A vaccine was developed, and the virologic tools were discovered with which to lay the groundwork for a vaccine against hepatitis C.
W N, Katkov, J L, Dienstag
openaire   +2 more sources

HEPATITIS A VACCINE

The Pediatric Infectious Disease Journal, 2000
Hepatitis A is an infectious disease frequently reported in the United States. An average of 26,000 cases were reported each year during 1980 to 1999; probably 3 times as many occurred. Hepatitis A vaccines provide a powerful new prevention tool. The 2 inactivated hepatitis A vaccines available as pediatric and adult formulations in the United States ...
openaire   +3 more sources

Hepatitis B vaccines

Clinics in Liver Disease, 2004
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
Andy S, Yu   +2 more
openaire   +3 more sources

Prevention of Hepatitis A with the Hepatitis A Vaccine

New England Journal of Medicine, 2004
A 34-year-old man presented to the emergency department two weeks after returning from a trip to India, reporting a six-day history of anorexia, vomiting, malaise, fatigue, and dark urine. His alanine aminotransferase level was 7330 U per liter, the bilirubin level was 8 mg per deciliter, and a test of the serum for hepatitis A IgM antibodies was ...
Allen S, Craig, William, Schaffner
openaire   +2 more sources

Home - About - Disclaimer - Privacy